Intracranial metastatic prostate carcinoma presenting as intermittent double vision

Urology. 2004 Sep;64(3):589-90. doi: 10.1016/j.urology.2004.04.073.

Abstract

We describe a prostate cancer patient whose initial symptom was intermittent double vision. Intracranial magnetic resonance imaging demonstrated a pituitary mass extending to the cavernous sinus, which caused the double vision. After hormonal therapy for prostate cancer, the pituitary mass disappeared, and double vision was completely resolved without local therapy for the brain. In the 19 months of follow-up after hormone treatment, the prostate cancer remained stable, and the patient remained neurologically intact.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / complications
  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary*
  • Aged
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Chlormadinone Acetate / therapeutic use
  • Diplopia / etiology*
  • Humans
  • Leuprolide / therapeutic use
  • Magnetic Resonance Angiography
  • Male
  • Pituitary Neoplasms / diagnosis
  • Pituitary Neoplasms / drug therapy
  • Pituitary Neoplasms / secondary*
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology*
  • Remission Induction

Substances

  • Antineoplastic Agents, Hormonal
  • Chlormadinone Acetate
  • Leuprolide